ScandiDos develops innovative Quality Assurance (QA) solutions that help radiotherapy clinics deliver safe, accurate, and efficient cancer treatments. Headquartered in Uppsala, Sweden, with offices in the United States, France, and China, ScandiDos supports clinics in more than 55 countries. Our measurement systems and software are designed to meet the demands of today's advanced radiotherapy techniques, enabling independent verification of treatment delivery with confidence. The Delta4 portfolio supports Patient QA, Machine QA, Motion Management QA, and stereotactic verification across modern treatment techniques, including IMRT, VMAT, SRS, SBRT, MRI, Radixact, TomoTherapy, and more. By combining innovative hardware with intelligent software, we help medical physics teams streamline their workflows while maintaining the highest standards of treatment quality and patient safety. ScandiDos AB (publ) is listed on Nasdaq First North Growth Market under the ticker SDOS.
Looking for a particular ScandiDos employee's phone or email?
The ScandiDos annual revenue was $5.6 million in 2026.
Gustaf Piehl is the President and CEO of ScandiDos.
31 people are employed at ScandiDos.
ScandiDos is based in Uppsala, Uppsala.
The NAICS codes for ScandiDos are [51, 511, 513, 33].
The SIC codes for ScandiDos are [38, 384].